Elmiron Update: Warnings Changed to Include Risk of Eye Damage
On June 16th, 2020, the Food and Drug Administration (FDA) announced labeling changes to Elmiron, a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss the potential dangers to consumers taking Elmiron, and how to seek legal representation if you or a loved one has suffered injuries from Elmiron.
Elmiron Used to Treat Bladder Pain Associated with Interstitial Cystitis
Elmiron is an oral prescription drug generally used to treat discomfort or bladder pain associated with interstitial cystitis, or IC, a chronic condition that causes bladder pain and pressure. Common side effects of Elmiron include but are not limited to, hair loss, abdominal pain, nausea and diarrhea. However, warnings about Elmiron have now been expanded to include potential damage to the eye, including pigmentary maculopathy and retinal damage. Pigmentary maculopathy is a degenerative eye disease that can lead to permanent vision loss.
Elmiron Warns of Potential Toxicity to the Retina
Jannsen Pharmaceuticals, manufacturer of Elmiron, has now updated their labels to reflect the possibility of potentially serious eye damage to consumers. This warning states that “pigmentary changes in the retina, reported in the literature as pigmentary maculopathy, have been identified with long term use of Elmiron.” In a 2019 study conducted by ophthalmologists, 24% of examined patients showed clear signs of Elmiron toxicity to the retina. Being the only currently approved drug in the United States to treat interstitial cystitis, many patients may have been exposed to the harmful effects of Elmiron as a result of treating their condition. Additionally, the damage caused by the drug could be mistaken for other conditions, such as age-related macular degeneration, so it is important to consult a medical professional for additional testing if you have been exposed to Elmiron.
Consult Baltimore Attorneys at Peter Angelos, P.C. If You Have Suffered an Injury From Elmiron
If you or a loved one has suffered injury after taking Elmiron, it is vital to consult professional counsel. The qualified product liability attorneys at Peter Angelos, P.C. make it their top priority to represent individuals who have fallen victim to harmful effects from large drug companies. If you have experienced symptoms of blurred vision, difficulty reading, partial vision loss or other forms of vision impairment, contact the attorneys at Peter Angelos, P.C. for a free consultation and assistance.